Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood

  • Authors:
    • Weihuang Liu
    • Jie Zhao
    • Qiaoqi Li
    • Qiaona Wang
    • Ying Zhou
    • Zan Tong
  • View Affiliations

  • Published online on: February 7, 2018     https://doi.org/10.3892/ol.2018.7990
  • Pages: 5087-5092
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Dendritic cells (DCs) are important in tumor immunology. Identifying DC subset markers in the peripheral blood, which are informative for gastric cancer stages, is not only useful for prognosis but may also provide mechanistic insights into processes facilitating therapy. The present study investigated plasmacytoid dendritic cells (pDCs) and myeloid CD1c+ dendritic cells (mDC1s) in the peripheral blood of patients with gastric cancer and healthy controls using flow cytometry. Using peripheral DC staining and subset analysis, patients with gastric cancer were identified to have substantially higher numbers of peripheral pDCs and mDC1s. In addition, there was a trend of elevated circulating pDCs with advanced stages and lymph node metastasis in gastric cancer, whereas no differences in circulating mDC1s were observed among the various groups. The results suggested that circulating pDCs are a positive prognostic indicator in patients with gastric cancer of different stages and highlighted the critical role of pDCs immunity in the development of gastric cancer.

References

1 

Veglia F and Gabrilovich DI: Dendritic cells in cancer: The role revisited. Curr Opin Immunol. 45:43–51. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Chang WJ, Du Y, Zhao X, Ma LY and Cao GW: Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Kashimura S, Saze Z, Terashima M, Soeta N, Ohtani S, Osuka F, Kogure M and Gotoh M: CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer. 15:144–153. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Xu DP, Shi WW, Zhang TT, Lv HY, Li JB, Lin A and Yan WH: Elevation of HLA-G-expressing DC-10 cells in patients with gastric cancer. Hum Immunol. 77:800–804. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Tsukayama S, Omura K, Yoshida K, Tanaka Y and Watanabe G: Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer. Oncol Rep. 14:369–375. 2005.PubMed/NCBI

6 

Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Xiangming C, Iwashige H, Aridome K, Hokita S and Aikou T: Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett. 159:103–108. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Niccolai E, Taddei A, Prisco D and Amedei A: Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol. 21:5778–5793. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Coutant F and Miossec P: Altered dendritic cell functions in autoimmune diseases: Distinct and overlapping profiles. Nat Rev Rheumatol. 12:703–715. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Swiecki M and Colonna M: The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 15:471–485. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Lombardi VC, Khaiboullina SF and Rizvanov AA: Plasmacytoid dendritic cells, a role in neoplastic prevention and progression. Eur J Clin Invest. 45 Suppl 1:S1–S8. 2015. View Article : Google Scholar

11 

Kini Bailur J, Gueckel B and Pawelec G: Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer. J Transl Med. 14:1512016. View Article : Google Scholar : PubMed/NCBI

12 

Sciarra A, Lichtner M, Autran GA, Mastroianni C, Rossi R, Mengoni F, Cristini C, Gentilucci A, Vullo V and Di Silverio F: Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients. Prostate. 67:1–7. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Huang XM, Liu XS, Lin XK, Yu H, Sun JY, Liu XK, Chen C, Jin HL, Zhang GE, Shi XX, et al: Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer. Cancer Sci. 105:150–158. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Demoulin S, Herfs M, Delvenne P and Hubert P: Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: Insight into the molecular mechanisms. J Leukoc Biol. 93:343–352. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Tamura T, Ohira M, Tanaka H, Muguruma K, Toyokawa T, Kubo N, Sakurai K, Amano R, Kimura K, Shibutani M, et al: Programmed death-1 Ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II/III gastric cancer. Anticancer Res. 35:5369–5376. 2015.PubMed/NCBI

16 

Kalb ML, Glaser A, Stary G, Koszik F and Stingl G: TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: Mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity. J Immunol. 188:1583–1591. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Tel J, Smits EL, Anguille S, Joshi RN, Figdor CG and de Vries IJ: Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. Blood. 120:3936–3944. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Gerlini G, Urso C, Mariotti G, Di Gennaro P, Palli D, Brandani P, Salvadori A, Pimpinelli N, Reali UM and Borgognoni L: Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes. Clin Immunol. 125:184–193. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Sawant A, Hensel JA, Chanda D, Harris BA, Siegal GP, Maheshwari A and Ponnazhagan S: Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol. 189:4258–4265. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, W., Zhao, J., Li, Q., Wang, Q., Zhou, Y., & Tong, Z. (2018). Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood. Oncology Letters, 15, 5087-5092. https://doi.org/10.3892/ol.2018.7990
MLA
Liu, W., Zhao, J., Li, Q., Wang, Q., Zhou, Y., Tong, Z."Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood". Oncology Letters 15.4 (2018): 5087-5092.
Chicago
Liu, W., Zhao, J., Li, Q., Wang, Q., Zhou, Y., Tong, Z."Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood". Oncology Letters 15, no. 4 (2018): 5087-5092. https://doi.org/10.3892/ol.2018.7990